Aelis Farma Reports Its 2022 Annual Financial Results and Confirms Its 2023 Outlook

BORDEAUX, France–(BUSINESS WIRE)–Regulatory News: Aelis Farma (ISIN: FR0014007ZB4 – Ticker: AELIS, PEA-PME eligible) (Paris: AELIS), a clinical-stage biopharmaceutical company specialized in the development of treatments for brain diseases, today announced its annual results for the year to December 31, 2022. Pier Vincenzo Piazza, CEO of Aelis Farma, said: “2022 was ... Read More

FOCL CBD: Taking It To The Next Level 

CBD, or cannabidiol, is a natural compound found in hemp and cannabis plants. It has become increasingly popular in recent years due to its potential health benefits. From relieving anxiety and reducing inflammation to helping with chronic pain, CBD has been used to treat a variety of ailments.  Now, with ... Read More